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Defensins constitute a major family of natural antimicrobial peptides that protect the host against
microbial invasion. Here, we report on the antibacterial properties and cellular interaction of
Human Defensin 5 as a function of its positive charge and hydrophobicity. We ﬁnd that selective
replacement of arginine residues in HD-5 by alanine or charge-neutral lysine residues reduces anti-
bacterial killing as well as host cell interaction. We identify arginines at positions 9 and 28 in the
HD-5 sequence as particularly important for its function. Replacement of arginine at position 13
to Histidine, as observed in a Crohn’s disease patient, reduced bacterial killing strain-selectively.
Finally, we ﬁnd that HD-5 interacts with host cells via receptor-mediated mechanisms.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Antimicrobial peptides constitute important effector molecules
of the innate immune system [1]. Despite their wide distribution in
nature, they vary in size, structure, amino acid sequence as well as
mode of antimicrobial activity [2,3]. Most antimicrobial peptides
are cationic and kill a broad range of microorganisms via disrup-
tion of negatively charged cytoplasmic membranes [4]. Defensins
form a large subfamily of antimicrobial peptides. Human defensins
are cysteine-rich, cationic peptides with molecular masses ranging
from 3 to 5 kDa. Based on the connectivity of the six conserved cys-
teine residues and sequence homology, human defensins are clas-
siﬁed into a and b families.
Both families of defensins have similar three-dimensional struc-
tures as determined by X-ray crystallography and NMR studies [5–
9], despite sequence variation and differing disulﬁde connectivity.
Defensins share a common fold of three-stranded anti-parallel b-
sheets constrained by three intra-molecular disulﬁde bonds. Hu-
man defensins were discovered originally as natural peptide anti-
biotics in neutrophils, and were termed Human Neutrophil
Peptides 1–3 or a-defensin 1–3 [10]. Subsequently, a fourth a-
defensin was discovered in neutrophils, termed HNP-4 [11–13].
More recently, two additional a-defensins were described, termed
Human Defensins 5 and 6 [14,15]. HD-5 and HD-6 are stored inlf of the Federation of European Bi
. de Leeuw).granules of specialized epithelial cells called Paneth cells in the
small intestine [16].
Recently, a speciﬁc deﬁciency of HD-5 was observed in patients
with ileal Crohn’s disease, a chronic inﬂammatory disease [17,18].
These ﬁndings have led to the notion that HD-5 as an innate im-
mune effector molecule may play an important role in the mainte-
nance of mucosal balance and that deﬁciency of HD-5, resulting in
weakening of mucosal antibacterial capacity may contribute to
pathogenesis [19]. Recently, we reported that HD-5, in addition
to its antibacterial activity, interacts with epithelial cells in a struc-
ture-dependent fashion [20]. Here, we examine the role of cationi-
city and hydrophobicity of HD-5 in bacterial killing and host cell
interaction. We further report on the nature of the interaction of
HD-5 with epithelial cells.2. Materials and methods
2.1. Materials
Chemicals used for solid phase peptide synthesis were obtained
as described [21]. Escherichia coli ATCC 25922 and Staphylococcus
aureus ATCC 29213 were from Microbiologics (St. Cloud, MN).
The Caco-2 cell line was obtained from the American Type Culture
Collection (Manassas, VA). Pertussis toxin, JNK inhibitor SP600125,
p38 inhibitor SB203580 and MAPK ERK inhibitor PD098059 were
purchased from Calbiochem.ochemical Societies.
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Chemical synthesis and folding of HD-5 and HD-5 mutant pep-
tides was carried out as described [21]. The molecular mass of the
peptides was veriﬁed by electrospray ionization mass spectrome-
try (ESI-MS) as described [21].
2.3. Crystallization, data collection, structure solution and reﬁnement
of HD-5 R13H
Crystals were obtained as described together with Supplemen-
tary Table 1, which summarizes data collection and reﬁnement sta-
tistics. The coordinates and structure factors have been deposited
in the PDB with accession code 3I5W. Molecular graphics were
generated using Pymol (http://pymol.org).
2.4. Antibacterial activity assay
The antibacterial activity of HD-5 peptides against E. coli ATCC
25922, S. aureus ATCC 29213, Enterobacter aerogenes ATCC 13048
or Bacillus cereus ATCC 10876 was carried out in a 96-well turbidi-
metric assay as described previously [22].
2.5. Cell culture
Subconﬂuent monolayers of Caco-2 cells were maintained in
RPMI 1640 medium (Gibco), supplemented with 10% FBS (Valley
Biomedical, Winchester, VA), 2 mM L-glutamine (Quality Biologi-
cal, Gaithersburg, MD), 20 mM HEPES, 1 nonessential amino
acids, 1 mM sodium pyruvate and 5% penicillin/streptomycin (Sig-
ma) in a humidiﬁed incubator at 37 C with 5% CO2. Caco-2 cells
were used between passages 18 and 35 and were plated at a den-
sity of 4  104 cells per cm2.
2.6. Evaluation of IL-8 secretion
Caco-2 cells were cultured in 96-well plates in the presence of
serum. Cells were gently washed twice with serum-free medium
and incubated for a further 24 h in serum-free medium containing
the peptides at a ﬁnal concentration of 50 lg/ml unless otherwise
indicated. In the presence of serum, the induction of IL-8 secretion
was not observed (not shown). The culture supernatant was col-
lected for measurement of IL-8 using the Luminex-100 system
(Bio-Rad).
To study the role of Ga1 in signal transduction, cells were pre-
incubated for 24 h in the presence of 500 ng/ml pertussis toxin
(Calbiochem) and further incubated for 24 h in serum-free medium
containing peptides at the indicated concentration. Cells were pre-
incubated for 2 h with SP600125 (15 lM), PD098059 (20 lM) or
SB203580 (20 lM) and further incubated for 24 h in serum-free
medium containing peptides at indicated peptide concentration.
Culture supernatants were collected for measurement of IL-8 using
the Luminex-100 system (Bio-Rad). Pretreatment of the cells did
not affect cell viability as measured by MTS assay.Fig. 1. Structure of HD-5 R13H. (A) Structural alignment of HD-5 R13H and wild-
type HD-5. Ca traces of two independent monomers of HD-5 R13H (green) were
superimposed on two monomers of wild-type HD-5 (grey) (1ZMP, [9]). Amino acids
side chains and three conserved disulﬁde bridges are shown in ball-and-stick mode.
(B) The electron density maps around mutated residue and disulﬁde bonds. 2Fo–Fc
maps were contoured at the 1r level.3. Results
3.1. Chemical synthesis of HD-5 peptides
The three-dimensional structure of HD-5 reveals a unique dis-
tribution of surface-exposed positive charges [9]. Two pairs of argi-
nine residues, one pair at positions 9 and 28 and another at
positions 13 and 32, are located on opposite sides of the molecule
in its three-dimensional structure [9]. To determine the function of
these positively charged residues, we replaced each pair of argi-nines with alanines (R928A and R1332A) or with charge-neutral
lysines (R928K and R1332K). To test the functional consequences
of increased hydrophobicity, we synthesized two analogues in
which phenylalanine at positions 4 or 27 were replaced by bi-
phenylalanine (Y4Bp and Y27Bp). Mutation of arginine 13 to histi-
dine is based on a polymorphism in the gene encoding HD-5 ob-
served in a patient diagnosed with ileal Crohn’s disease, which
encodes this sequence variation (C.L. Bevins, J.P. Achkar, and G.
Casey, personal communication). All HD-5 peptides were synthe-
sized, folded and characterized using the protocol for HD-5 and
the observed molecular masses agreed with their respective calcu-
lated average isotopic values (Supplementary Fig. 1).
To verify the pairings of the cysteine residues and conﬁrm in de-
tail a scope of molecular changes induced by the mutation we
determined the high-resolution X-ray structure of HD-5 R13H.
HD-5 R13H readily crystallized and crystals diffracted to 1.63 Å
resolution at our home X-ray source. Two crystallographically
independent monomers of defensin present in asymmetric unit
display a very well-conserved fold and single site mutations does
not introduce changes in its overall structure and the topology of
the dimer formed by them in the crystal (Fig. 1A). The level of
structural similarity is expressed by low values of the root mean
square deviations between superimposed monomers (rmsd in
the range of 0.48–0.84 Å calculated for the eight possible align-
ments of two independent monomers of HD-5 R13H mutant and
four independent monomers of wild-type HD-5) and dimers (rmsd
in the range of 0.86–0.98 Å calculated for the alignments of HD-5
R13H dimer and two dimers of wild-type HD-5).
The electron density clearly conﬁrmed both identity of the
mutation and connectivity of disulﬁde bonds, which are paired
identical to the wild-type hD5 (Fig. 1B). The lack of extended
changes in the architecture of mutant leads us to the conclusion
that the changes in biological activities observed for these peptides
resulted from the chemical and not the structural changes, intro-
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these mutations in bacterial killing and host cell interaction.
3.2. The antibacterial activity of HD-5 depends on its cationicity and is
greatly diminished by salt
We examined the antibacterial activity of the HD-5 peptides
against E. coli ATCC 25922, E. aerogenes ATCC13048, S. aureus ATCC
29213 and B. cereus ATCC 10876 using virtual colony counting as
established previously [22]. In this assay, bacteria are exposed to
a twofold 10-time serial dilution of peptides for 2 h in 10 mM so-
dium phosphate buffer pH 7.4. Subsequently, the antimicrobial
activity of the peptides is neutralized by the addition of Mueller
Hinton medium and optical density is recorded for a period of
12 h as a measure for bacterial recovery. Bacterial survival curves
against HD-5 peptides are shown in Fig. 2.
As described previously, HD-5 efﬁciently killed all bacterial
strains and, at comparable peptide concentration, proved more[defensin] (µg/ml)
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Fig. 2. (A) Survival curves of E. coli ATCC 25922, S. aureus ATCC 29213, E. aerogenes and
peptides at concentrations varying twofold from 1 to 256 lg/ml, except for B. cereus w
exposed to ﬁxed peptide concentrations (100 lg/ml for E. coli; 50 lg/ml for S. aureus) in
are the mean of three separate experiments with the exception of the E. aerogenes and
survival could not be plotted.toxic towards S. aureus and B. cereus as compared to E. coli or E. aer-
ogenes [22]. In general, replacement of arginine residues by alanine
dramatically reduced bacterial killing against all strains tested. In
particular, replacement of arginines at positions 13 and 32 was
detrimental for killing of both gram-negative strains. The R928A
peptide retained residual activity against these strains, however
only at high peptide concentrations. Both the R928A and the
R1332A peptides showed residual but weakened activity against
the gram-positive bacteria, in particular against B. cereus.
Replacement of arginines by lysine residues affected bacterial
killing strain-selectively. Killing of E. coli, E. aerogenes or B. cereus
by both the HD-5 R928K and R1332K peptides was comparable
to the wild-type peptide. Interestingly, replacement of arginine
by lysine at positions 9 and 28 signiﬁcantly reduced the killing of
S. aureus, whereas the R1332K peptide showed activity against this
strain comparable to HD-5. Increased hydrophobicity did not sig-
niﬁcantly alter the antibacterial activity against the tested strains.
Surprisingly, the single mutation of arginine to histidine severely[defensin] (µg/ml)
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B. cereus experiments, which were carried out in duplicate. Points scored as zero
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enes compared to wild-type, but left killing of E. coli or B. cereus
unaffected.
The antibacterial killing of cationic peptides like defensins is
blocked by salt, presumably because of weakening electrostatic
interactions with the negatively charged bacterial membrane.
Therefore, we measured bacterial killing of the HD-5 peptides at
a ﬁxed concentration (100 lg/ml for E. coli; 50 lg/ml for S. aureus)
in the presence of increasing concentrations of sodium chloride
(Fig 2B). As observed previously, bacterial killing by HD-5 was
greatly diminished by salt [20]. Killing of E. coli was more salt-sen-
sitive than killing of S. aureus. As expected, killing by the R928A
and R1332A peptides was reduced almost completely at low con-
centrations of sodium chloride. The bactericidal activity of the
R928K and R1332K peptides against E. coli was reduced compara-
bly to wild-type HD-5. Killing of S. aureus by these peptides how-
ever appeared more salt-sensitive. As observed under low-salt
conditions, increased hydrophobicity did not signiﬁcantly alter
the salt-dependent bacterial killing. Interestingly, the bactericidal
activity of the HD-5 R13H peptide was dramatically reduced by
salt, most notably against S. aureus. Taken together, these data
indicate positive charge in the form of arginine residues is impor-
tant for bacterial killing by HD-5. Furthermore, increase of sodium
chloride concentrations resembling physiological conditions
greatly diminishes the antibacterial capacity of HD-5.
3.3. Host cell interaction of HD-5 depends on its cationicity
In an earlier study, we found that HD-5 induced the secretion of
the chemokine IL-8 by intestinal epithelial cells in a concentration-
and structure-dependent fashion [20]. We tested the role of posi-
tive charge and hydrophobicity of HD-5 on host cell interaction
by exposing the peptides to Caco-2 cells. We determined the secre-
tion of IL-8 induced by HD-5 and HD-5 mutant peptides as a mea-
sure of cellular interaction (Fig. 3). Preliminary studies using RT-
PCR indicate that HD-5 induces the expression of IL-8 mRNA, but
not MCP-1, interleukin 1-b, GM-CSF or RANTES mRNA in a concen-
tration-dependent fashion in the Caco-2 cell line (data not shown).
Replacement of arginines by alanine residues irrespective of their
positions reduced the secretion of IL-8, suggesting that these resi-
dues are important for cellular interaction. Surprisingly, the
charge-neutral mutations of arginine to lysine reduced the ob-
served IL-8 secretion, in particular at positions 9 and 28. IncreasedC
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Fig. 3. IL-8 secretion by Caco-2 cells in the absence or presence of HD-5 or HD-5
derivative peptides at a ﬁnal concentration of 50 lg/ml. Following incubation for
24 h, culture supernatants were analyzed for IL-8 using the Luminex-100 system in
duplicate. Data represent mean and S.D. of three individual experiments.hydrophobicity at position 4 did not signiﬁcantly alter the host cell
interaction; however the interaction was negatively affected by in-
creased hydrophobicity at position 27. The mutation of arginine to
histidine at position 13 slightly, but not signiﬁcantly, reduced the
observed IL-8 secretion compared to wild-type HD-5. In conclu-
sion, these data suggest that the HD-5 interaction with epithelial
cells is arginine-dependent, in particular arginines at positions 9
and 28.
3.4. The HD-5 epithelial cell interaction is receptor-mediated
Previously, we observed that HD-5 binds to the cell membrane
of intestinal epithelial cells [20]. In addition, it was reported re-
cently that a-defensins chemoattract various leucocyte subsets
[23], suggesting receptor-mediated interactions. In order to exam-
ine whether the cellular interactions of HD-5 we observed were
receptor-mediated, we reasoned that a HD-5 peptide entirely com-
posed of D-amino acids would be unable to interact with L-proteins
and therefore would be unable to induce IL-8 secretion. Therefore,
the D-form of the peptide was synthesized, folded and purity and
mass was conﬁrmed by HPLC and mass spectrometry using the
protocols established for the L-form of HD-5 (Wei et al., submitted
for publication). As shown in Fig. 4A, the D-form of the peptide did
not induce IL-8 secretion compared to the L-form, suggesting a
receptor-mediated interaction. Furthermore, the effects of L-HD-5
were not inhibited by the presence of the D-form, suggesting that
the observed HD-5 mediated IL-8 induction is mediated through
some form of stereo-speciﬁc interaction. Interestingly, Human b-
Defensin 2 (HBD-2) did not induce the secretion of IL-8 by Caco-
2 cells, suggesting a speciﬁc effect for HD-5. The D-peptides
showed equal antibacterial activity against E. coli, but were less
efﬁcient compared to the L-form against S. aureus, indicating that
the D-peptides are biologically active (Wei et al., submitted for
publication).
To further investigate whether the interaction of the defensins
with Caco-2 is receptor-mediated, we took a pharmacological ap-
proach. Caco-2 cells were preincubated in the presence of pertussis
toxin, a general inhibitor of G protein-coupled receptors. We ob-
served that pre-incubation with pertussis toxin modestly de-
creased the observed IL-8 secretion by HD-5. Caco-2 cells have
been shown to respond slowly to pertussis toxin treatment [24],
which may in part explain this relatively modest effect. G pro-
tein-coupled receptors are known to be connected to the MAPK
signaling pathways by classical G protein-stimulated synthesis of
second messengers [25]. Therefore, cells were preincubated with
inhibitors speciﬁc for the three major classes of MAPK: SB203580
(MAPK p38), PD098059 (MAPK ERK) or SP600125 (MAPK JNK). Cell
viability in these experiments was not affected by pre-treatment of
the cells with the inhibitors as determined by MTS assays (data not
shown). Cells were subsequently exposed to HD-5 and the amount
of IL-8 in the supernatant was determined (Fig. 4B). HD-5 signaling
in Caco-2 cells was found to be inhibited speciﬁcally by the MAPK
p38 and, to a lesser extent, the MAPK ERK inhibitors. Together,
these observations suggest that HD-5 interacts with epithelial cells
through a receptor-mediated mechanism.4. Discussion
The distribution of positive charge and hydrophobicity is gener-
ally suggested to determine the antibacterial activity of cationic
antimicrobial peptides. We and others have shown that replace-
ment of arginine residues in defensins or other antimicrobial pep-
tides reduces bacterial killing signiﬁcantly [26–28]. Previously, we
reported that in a-defensins, there is a selection of arginine over ly-
sine residues [26]. We showed that replacement of all arginine res-
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Fig. 4. (A) Induction of IL-8 secretion in Caco-2 cells exposed to L-forms or D-forms
of HD-5 as indicated. Cells were exposed to the peptides for 24 h at 50 lg/ml in
serum-free medium. Culture supernatants were analyzed for IL-8 using the
Luminex-100 system. Data represent mean and S.D. of one experiment carried
out in triplicate out of three individual experiments, with the exception of L-HD-5
plus D-HD-5 which was carried out in duplicate. (B) Induction of IL-8 secretion in
Caco-2 cells exposed to HD-5 at 50 lg/ml Cells were preincubated with the p38
inhibitor SB203580 (SB; 20 lM), JNK inhibitor SP600125 (SP; 15 lM), ERK inhibitor
PD098059 (PD; 20 lM) or pertussis toxin (Ptx; 200 ng/ml) for 2 h. Subsequently,
cells were exposed to the peptides for 24 h in serum-free medium. Culture
supernatants were analyzed for IL-8 using the Luminex-100 system. Data represent
mean and S.D. of one experiment carried out in triplicate out of three individual
experiments.
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other defensin, Human Neutrophil Peptide 1 (HNP1), attenuated its
bacterial killing. In particular, we found that the lysine-containing
peptide killed the bacteria more slowly and reduced toxicity of the
peptide against S. aureus especially.
Here, we expand and nuance these studies by reporting on the
antibacterial killing of HD-5 peptides in which selective arginines
were mutated. It is important to keep in mind that all the peptides
in this study still contain arginine residues, for example, the
R1332K peptide contains arginines at positions 9 and 28. Interest-ingly, we found arginine to lysine mutations at positions 9 and 28
in HD-5 dramatically reduced host cell interaction and S. aureus
killing, identifying these two residues as a functional ‘‘hotspot” in
HD-5. In addition, we observed that a single mutation of arginine
to histidine as found in a patient suffering from Crohn’s disease se-
verely attenuates the bactericidal activity of HD-5, in particular
against S. aureus. This is an interesting observation, since dimin-
ished levels of HD-5 have been linked to ileal Crohn’s disease
[17]. The antibacterial ability of this peptide was particularly sen-
sitive to increased concentrations of salt, a condition that more
realistically mimics the ileal environment. Diminished bacterial
killing by the HD-5 R13H peptide could contribute to a weakened
innate defense or, alternatively, could contribute to an imbalance
in gut microﬂora, mechanisms that both have been suggested to
be involved in Crohn’s disease [17,29]. It is important to note how-
ever, that the antibacterial activity of wild-type HD-5 is greatly
diminished under buffer conditions that simulate small intestinal
ﬂuid up to a concentration of 256 lg/ml (unpublished observa-
tion). Our results clearly indicate that arginine residues are criti-
cally important for HD-5 function. The polar residues arginine
and lysine both contain amphiphilic side chains, however the ly-
sine side chain is more hydrophobic [30]. Most importantly, argi-
nine has an enhanced ability for electrostatic interactions
compared to lysine [31]. However, for other classes of cationic pep-
tides, highly variable results for the importance of arginine versus
lysine residues in bacterial killing have been reported [32–34].
Interestingly, mutation analysis of Human Neutrophil Peptide 1,
a closely related human a-defensin, suggests that hydrophobicity
instead of cationicity can play a dominant role in various defensin
functions (unpublished observations). It remains to be investigated
whether this is the case for HD-5 also.
Previously, we showed that HD-5 interacts with epithelial cells
and localizes on the cell membrane surface [20]. Here, we expand
on this study and show that HD-5 likely interacts via a receptor-
mediated process and that arginines are important for host cell
interaction. One main line of evidence that supports the notion
that host cell interactions of defensins are receptor-mediated is
their ability to chemoattract a variety of cell types. b-defensins
were shown to selectively chemoattract immature dendritic cells
and memory T lymphocytes [35,36]. In the case of human b-defen-
sin 2 (hBD2), the observed chemotaxis of immature dendritic cells
and memory T cells was shown to result from directly binding the
chemokine receptor CCR6 [35]. Interestingly, a mutation in b-
defensin was found to cause black coat color in the domestic
dog, involving an interaction between the defensin and the mela-
nocortin 1 receptor [37].
Speciﬁc receptors for the chemotactic activity of a-defensins
have not been identiﬁed. The capacity to chemoattractant mono-
cytes was ﬁrst described for Human Neutrophil peptides [38]. Sub-
sequently, HNPs were shown to chemoattract different subsets of T
lymphocytes and immature dendritic cells [39,40]. Several studies
however have shown that also for a-defensins this activity is
blocked by pertussis toxin, indicating the involvement of Gia-cou-
pled receptors [40,41]. The chemoattractant properties of a-defen-
sins has been assessed recently [23]. It was reported that a-
defensins chemoattract macrophages, mast cells and both naïve
as well as memory T lymphocytes, but not dendritic cells. In this
study, chemo-attraction by a-defensins was found to depend pre-
dominantly on the p38 and ERK MAPK pathways, in agreement
with our ﬁndings using epithelial cells. Previously, we have shown
by confocal microscopy that HD-5 labeled with rhodamine binds to
the cell surface of Caco-2 cells, but a small percentage of the la-
beled HD-5 could also be observed intra-cellular [20]. Therefore,
a secondary mechanism involving defensin binding to an intracel-
lular target can not be ruled out. Combined, these studies and our
ﬁndings suggest receptor-mediated mechanisms for a-defensins,
2512 E. de Leeuw et al. / FEBS Letters 583 (2009) 2507–2512as observed for b-defensins, expanding their role in innate
immunity.
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